Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Ascension's PyroCarbon foot implant:

This article was originally published in Clinica

Executive Summary

Ascension Orthopedics has received US FDA 510(k) approval to sell its first PyroCarbon implant for use in the lower extremities. The PyroSphere device is designed for the fourth and fifth tarsometatarsal joints in people suffering from the debilitating effects of arthritis in the foot. The Austin, Texas firm noted that it has expanded its product platforms to include arthroplasty, trauma and tissue regeneration. It currently offers over 10 arthroplasty products, a complete elbow trauma set and a tissue regeneration portfolio.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT052029

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel